Moderna’s COVID-19 Vaccine Price Will Be Test of US Negotiating Power

 
• By Sarah Karlin-Smith

Drug pricing experts are concerned the US government may not follow through on its commitment to pay less for COVID-19 vaccines it has helped fund given reports Moderna may be pushing a $50-$60/course price. The US also has little ability to control pricing in the private market – even for some government payers.

test tube with blood for Covid-19 analyzing and ampoules of vaccine are on stack of dollars. Price drugs coronavirus.
Moderna's hefty government funding will draw particularly scrunity to its COVID-19 vaccine price • Source: Shutterstock

More from Vaccines

More from Pink Sheet